Skip to main content
. 2016 Mar 4;56(5):249–256. doi: 10.2176/nmc.oa.2015-0285

Table 3.

Clinical features related to a history of chronic epilepsy

Case Age/gender (yrs) Age at onset (yrs) Disease duration (yrs) Neurological deficit including mental retardation, cognitional disorder (y/n) Frequency of ictus Classification and diagnosis of epilepsy EEG findings Time from final ictus (yr/month) Anti-psychotic drug (y/n) AED



GTC(n/yr) SPS/CPS (n/month) Focal (F)/Generalized (G) No. Name
1 33M 27 6 y, autism spectrum disorder 0 0–1 unknown unknown unknown 2 yrs y 1 CBZ
2 43F 14 29 n 1–2 G IGE (probable) unknown 4 months n 2 ZNS GBP (VPA withdrawal)
3 45F 19 25 n 3≦ G IGE (probable) lt.dominant 3–4 Hz poly spike and slow wave complex 1 yr n 4 VPA CLB PB CBZ
4 20M 0.5 19 y, febrile-induced convulsion 0 0–1 unclassified severe myoclonic epilepsy in infancy (probable) diffuse poly spike and slow wave complex 11 yrs n 1 VPA
5 34M 3 31 y 0–1 F rt. occipital epilepsy spike diminant at rt. occipital lobe 3 yrs n 1 PHT
6 9M 3 6 y, neonatal SAH, non-febrile convulsion 0 F rt. temporal epilepsy spike dominant at rt. occirital lobe 6 yrs n 0
7 52F 14 38 y 5 F temporal epilepsy unknown occurring frequently y 2 GBP CBZ
8 25M 1.5 24 y, non-febrile convulsion 5 F frontal epilepsy unknown occurring frequently n 4 VPA CBZ TOP LEV
9 34M 30 4 n, viral meningitis 2 F lt. temporal epilepsy spike dominant at lt. temporal lobe 5 months n 2 ZNS VPA (dose adjustment)
10 45F 10 35 y 1–2 G symptomatic generalized epilepsy unknown unknown y 1 VPA

AED: anti-epileptic drug, CBZ: carbamazepine, CLB: clobazam, CPS: complex partial seizure, EEG: electroencephalogram, F: female, F: focal, G: generalized, GBP: gabapentin, GTC: general tonic seizure, IGE: idiopathic generalized epilepsy, LEV: levetiracetam, lt: left, M: male, n: no, PHT: phenytoin, rt: right, SPS: simple partial seizure, TOP: topiramate, VPA: valproic acid, y: yes, ZNS: zonisamide.